SAMNIR is used for the treatment of patients with infections caused by susceptible strains of the bacteria (in the list as follows).
Upper respiratory tract infections; acute bacterial otitis media, acute maxillary sinusitis, acute recurrent or chronic tonsil/pharyngitis.
Lower respiratory tract infections; community-acquired pneumonia, acute exacerbation of chronic bronchitis, secondary bacterial infections of acute bronchitis.
Uncomplicated skin and skin structure infections.
NOTE: Cefdinir has not been shown effective in the prevention of rheumatic fever following Streptococcus pyogenes pharyngitis/tonsillitis.